The "reverse dipping" blood pressure (BP) pattern has been studied among the general population and in individuals suffering from hypertension. However, the prognosis of this pattern in chronic kidney disease (CKD) patients is not known. We monitored BP throughout the day and followed health outcomes in 588 CKD patients admitted to our hospital. Time to all-cause mortality, cardiovascular mortality, renal events and cardiovascular events was recorded. Multivariate-adjusted Cox regression analyses were carried out to detect the prognostic value of a reverse dipping BP pattern. Prevalence of a "dipper", "non-dipper" and "reverse dippers" was 34.69%, 43.54% and 18.03%, respectively. Patients with a reverse dipping pattern had a higher prevalence of total mortality, cardiovascular mortality, renal events and cardiovascular events than patients with a dipping pattern (P < 0.025). Multivariateadjusted Cox regression analyses showed that reverse dippers (versus dippers) were associated with a higher risk of total mortality (hazard ratio [HR], 5.08; 95% confidence interval [CI], 1.79~14.47), cardiovascular mortality (4.17; 1.25~13.88), renal events (3.00; 1.59~5.65) and cardiovascular events (4.12; 1.78~9.51) even after adjustment by 24-h systolic BP. These data suggest that a reverse dipping BP pattern, independent of 24-h levels of systolic BP, has prognostic value in CKD patients not undergoing dialysis.
Incidence of events. With regard to total mortality, median follow-up was 35 (interquartile range (IQR):
24-49) months, and total follow-up amounted to 1762 patient-years. During follow-up, 44 patients died (event incidence: 24.98 per 1000 patient-years). Causes of death were: fatal heart failure (22 patients); acute myocardial infarction (10) ; stroke (7); malignant tumor (4); gastrointestinal bleeding (1) . Hence, 39 patients among this cohort died of cardiovascular events (event incidence: 22.00 per 1000 patient-years).
With regard to renal events, median follow-up was 31 (IQR: 19-45) months, and total follow-up time amounted to 1594 patient-years. During follow-up, 140 renal events were recorded in this cohort (event incidence: 87.83 per 1000 patient-years).
With regard to cardiovascular events, median follow-up was 34 (IQR: 24-49) months, and total follow-up time amounted to 1717 patient-years. During follow-up, 74 cardiovascular events were recorded (event incidence: 43.10 per 1000 patient-years): 39 fatal events (as described above) and 35 non-fatal events (27 heart failures, 7 acute myocardial infarctions, and 1 acute arterial occlusion of lower extremities).
Risks associated with reverse dippers.
Crude and standardized prevalence of total mortality, cardiovascular mortality, renal events and cardiovascular events was higher in reverse dippers than in dippers (P < 0.025) ( Table 2 ). With respect to total mortality, cardiovascular mortality, renal events and cardiovascular events, there was a significant difference among the three survival curves (P < 0.001). For all endpoints, survival of reverse dippers was lower than that of dippers (P < 0.025) (Fig. 2) .
A competing risks model was carried out to identify the hazard ratios. In partly adjusted models, having a reverse dipping BP pattern (versus having a dipping BP pattern) was associated with a higher risk of total mortality (hazard ratio [ Table 1 . Differences of baseline characteristics in Chinese non-dialysis CKD patients. BMI: body mass index; CKD: chronic kidney disease; DBP: diastolic blood pressure; eGFR: estimated glomerular filtration rate; HDL-C: high-density lipoprotein cholesterol; iPTH: intact parathyroid hormone; LDL-C: low-density lipoprotein cholesterol; RAS: renin-angiotensin system; SBP: systolic blood pressure. P-value for analysis of variance or χ 2 test between 4 groups. Choosing dippers as reference group, and comparing the 3 other groups (non-dipper, reverse-dipper, extreme dipper) to this group throughout. * indicated comparison with the dippers P < 0.017. renal events (3.34; 1.81~6.14) and cardiovascular events (4.75; 2.05~11.00); Also, having a non-dipping pattern (versus having a dipping BP pattern) was associated with a higher risk of renal events (1.92; 1.09~3.37). When these models were also adjusted for 24-h BP, having a reverse dipping BP pattern (versus having a dipping BP pattern) continued to be associated with a higher risk of total mortality (5.08; 1.79~14.47), cardiovascular mortality (4.17; 1.25~13.88), renal events (3.00; 1.59~5.65) and cardiovascular events (4.12; 1.78~9.51); while non-dippers was no longer associated with prognosis (Table 3) . 
Discussion
In this prospective cohort study, 588 CKD patients not undergoing dialysis were enrolled and followed prospectively for a mean duration of 35 months. Patients with a reverse dipping BP pattern showed a worse prognosis compared with patients with a dipping BP pattern. A reverse dipping BP pattern was associated with an increased risk of total mortality, cardiovascular mortality, renal events and all cardiovascular events even when adjusted by 24-h SBP, but the significant association between a non-dipping BP pattern and prognosis disappeared after adjustment by 24-h SBP. Taken together, these results suggest that a reverse dipping BP pattern, rather than a non-dipping BP pattern, independent of 24-h SBP, is a risk factor for the prognosis in Chinese CKD patients not undergoing dialysis. Hence, special attention should be paid to a reverse dipping BP pattern in CKD patients.
Studies have shown that a non-dipping BP pattern is correlated with an increase in target-organ damage and cardiovascular events in hypertensive and normotensive subjects, and this BP pattern has been considered to be an additional risk factor for CVDs [15] [16] [17] . Compared with a non-dipping BP pattern, a reverse dipping BP pattern does not involve a fall in BP at night 12 . In a study looking at the role of a reverse dipping BP pattern in non-CKD elderly patients with sustained hypertension, reverse dippers had approximately twice the risk for stroke compared with dippers or non-dippers 18 . A study by Ohkubo T. and colleagues suggested that a decrease in nocturnal BP fall was significantly associated with an increase in the risk of cardiovascular mortality in hypertensive patients 19 . They also found that patients with a normal BP range and diminished nocturnal reductions in BP had an increased risk of cardiovascular mortality 19 . However, few reports on a reverse dipping BP pattern in CKD patients have been carried out. Minutolo et al. showed that CKD patients who were non-dippers and those who were reverse dippers had an increased risk of renal-related death and cardiovascular events 7 . Data on the role of a reverse dipping BP pattern in Chinese CKD patients are lacking. We were the first to report that the prevalence of a reverse dipping BP pattern is associated with target-organ damage in Chinese CKD patients, and suggested that reverse dippers have a worse prognosis. We found a reverse dipping BP pattern to be associated with an increased risk of total mortality, cardiovascular mortality, renal events and all cardiovascular events even when adjusted by 24-h SBP. Also, the association between a non-dipping BP pattern and increased risk of total mortality, cardiovascular mortality, renal events and all cardiovascular events was lost after adjustment by 24-h SBP. Hence, we should pay more attention to a reverse dipping BP pattern, rather than a non-dipping pattern, in Chinese CKD patients.
Patients with a reverse dipping BP pattern had nocturnal increases in BP, whereas individuals with a dipping pattern had a nocturnal fall in BP of 10-20%. Hence, the reverse dipping pattern is opposite to the physiologic rhythm of BP. Nocturnal BP represents the minimal BP needed for adequate perfusion of organs in healthy subjects 20 . Maintenance of a high BP at night overloads the cardiovascular system, with a consequent negative impact on the heart and vascular structures. It was not surprising to find that reverse-dipper CKD patients had a worse prognosis. Therefore, lowering nocturnal BP and normalizing the BP pattern might help to reduce the risks of CVD and renal disease for such CKD patients. Antihypertensive chronotherapy could be used to lower nocturnal BP and normalize the BP pattern 21 . Previously, we showed the advantages of bedtime scheduling of valsartan (80-320 mg, once daily for 1 year) in 60 patients with CKD 22 . Further prospective randomized clinical trials are needed to ascertain if antihypertensive chronotherapy has a beneficial effect on CKD patients.
The present study had six main limitations. First, all patients were from a single center. Second, all CKD patients underwent only one ABPM, so we could not rule out changes in subsequent ABPM. Third, patients who are willing to finish their first follow-up were enrolled, whereas patients who refused to complete follow-up were excluded, which led to a bias. Fourth, all patients did not accept standard therapy, so we could rule out the effect of drugs. Fifth, the clinical and significant differences in baseline characteristics between groups, though adjusted by the most common risk factors, might have affected our results. Finally, the etiology of our CKD patients varied. Table 3 . Risk of total mortality, cardiovascular mortality, renal events and cardiovascular events in reverse dippers. Data are hazard ratios (95% CI), followed by the P value, which express the risk of non-dippers (versus dippers) and reverse dippers (versus dippers). Partly adjusted hazard ratios were adjusted for age, gender, diabetes mellitus, smoking and drinking, body-mass index, history of cardiovascular disease, eGFR, hemoglobin, phosphate, cholesterol, proteinuria and on RAS blockade. In fully adjusted models, they were additionally adjusted for 24 h blood pressure.
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The underlying etiology (e.g., DM) may have affected the BP pattern, which may have led to different results in different CKD patients.
In conclusion, we have provided the first evidence that a reverse dipping BP pattern, independent of 24-h SBP, has prognostic value in Chinese CKD patients not undergoing dialysis. Further, prospective randomized clinical trials are needed to clarify if correction of BP patterns by administration of antihypertensive drugs at night improves the prognosis and attenuates progression of CVD and renal disease in CKD patients.
Methods
Study Population. The study protocol was approved by the ethics committee of the Third Affiliated Hospital of Sun Yat-sen University (Guangdong, China), and was approved by the Institutional Review Board. All methods were carried out in accordance with approved guidelines. Written informed consent was obtained from patients before enrollment. In this prospective cohort study, inpatients were recruited from July 2010 to December 2014. All information was extracted from our entire in-patient ABPM research database which was set up by our research group.
Inclusion criteria were patients: age ≥ 14 but < 75 years; with CKD; who promised to return to the Third Affiliated Hospital of Sun Yat-sen University to complete the first follow-up (i.e., 6 months after the baseline survey).
Exclusion criteria were patients: with acute changes in the eGFR > 30% in the previous 3 months; undergoing dialysis; who had undergone kidney transplantation; with atrial fibrillation; with cardiovascular events in the previous 3 months; who were pregnant; had night-work or shift-work employment; could not tolerate ABPM; had invalid ABPM data.
697 CKD patients fulfilled inclusion criteria, 71 patients who fulfilled exclusion criteria were excluded and the detailed reasons could be found in Fig. 1 . 38 patients were lost to follow-up after their first visit. Finally, 588 CKD patients were enrolled in this study.
Measurements. Ambulatory Blood pressure monitoring. Patients underwent 24-h ABPM using a TM-2430
Monitor (A&D, Tokyo, Japan) as reported previously 23, 24 . Briefly, cuff size was chosen based on arm circumference and applied to the non-dominant arm. BP was recorded every 15 min in daytime, and every 30 min at nighttime. Monitoring was done on a working day. Patients were asked to attend to their usual activities but to keep motionless at the time of measurement.
BP was measured for each patient during a visit to the physician. Sphygmomanometer measurements were recorded by the same physician, who was not aware of the results of ABPM recordings, as detailed elsewhere 23, 24 . Briefly, measurements were taken in a quiet environment using a mercury sphygmomanometer with the patient in a sitting position after 5 min of rest. BP was not measured if the patient had consumed tobacco, ingested caffeine, or eaten within the previous 30 min. SBP and DBP values (Korotkoff 's phase I and phase V, respectively) at each visit enabled recording of a minimum of three BP measurements at intervals of ≥ 1 min.
Collection of other data. We collected urine samples from 7 AM to 7 AM the next day to identify the extent of proteinuria and sodium levels over 24 h. These patients were asked to void their bladders before and after urine collection. Proteinuria was measured by immunoturbidimetry. In addition, medical history, including demographic, laboratory data (hemoglobin, albumin, calcium, phosphorus, iPTH, serum fasting glucose, cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), homocysteine, uric acid, serum creatinine, BUN), and current therapy were obtained at the initial study visit. All experimental data were measured using a 7180 Biochemistry Auto-analyzer (Hitachi, Tokyo, Japan).
"ABPM daytime" and "ABPM nighttime" were defined according to patients' schedules. Participants with a reduction in SBP of ≥ 10% but < 20% at nighttime compared with daytime were considered to have a dipping BP pattern. An extreme dipping BP pattern referred to a reduction at nighttime of > 20%. A non-dipping BP pattern referred to a < 10% reduction at nighttime. A reversed dipping BP pattern referred to higher SBP at nighttime compared with daytime 11 . CKD was defined according to the KDIGO 2012 clinical practice guideline 25 . eGFR was calculated using 2009 CKD-EPI creatinine equation 26 . DM was defined as the need for anti-DM drugs or meeting the diagnostic criteria based on the Standards of Medical Care in Diabetes 27 set by the American Diabetes Association.
Outcomes. Primary endpoints were time to all-cause mortality and time to cardiovascular mortality. Secondary endpoints were time to renal events and time to cardiovascular events. Cardiovascular mortality was defined as death caused by cardiovascular events. Renal events were a composite of doubling of serum creatinine or end-stage renal disease (ESRD), whichever occurred first. The endpoint of ESRD was reached on the day of the first dialysis session 28 . Cardiovascular events comprised fatal or non-fatal cardiovascular events: myocardial infarction, heart failure, revascularization, stroke, and other events (acute arterial occlusion of the lower extremities and thrombotic occlusion of the retinal artery), whichever occurred first. Cause of death was identified according to death certificates and autopsy reports based on the tenth revision of the International Classification of Disease. Hospital records were collected to establish the diagnosis based on criteria set by the American College of Cardiology and the European Society of Cardiology 29, 30 . Patients were followed up until 31 March 2016, or death, and censored on the date of the last visit to the nephrology clinic.
Statistical Analyses. Descriptive statistics are the mean ± SD for continuous variables and median values/ interquartile range for nonparametric variables. Frequency and percentages are used for categorical variables.
Comparisons of continuous variables between groups were evaluated by the Student's t-test, or nonparametric tests. Differences among categorical variables were analyzed using the χ 2 test or Fisher's exact test. Comparisons of continuous variables among groups were evaluated by ANOVA, or nonparametric tests. P-values for multiple comparisons were corrected according to the Bonferroni method.
We used STATA v14.0 to calculate the prevalence of endpoints. Crude rates and rates standardized by the direct method for sex and age are reported. Comparison of event rates among groups was done by the log-rank test. P-value for multiple comparisons was corrected according to the Bonferroni method.
We used Kaplan-Meier survival curves plotted according to current recommendations 31 , and the log-rank test to compare survival rate in different groups.
We used a competing risks model to compute hazard ratios associated with reverse dippers and non-dippers relative to dippers with regard to total mortality, cardiovascular mortality, renal events and cardiovascular events. In partly adjusted models, HRs were adjusted for age, sex, DM, cigarette smoking, alcohol consumption, body mass index, history of CVD, eGFR, hemoglobin level, phosphate level, cholesterol level, proteinuria and blockade of the renin-angiotensin system. In fully adjusted models, HRs were adjusted for these same parameters but also for 24-h BP.
All P-values were two-sided and the level of the test (α ) was set as 0.05. Data were analyzed using SPSS v20.0 (IBM, Armonk, NY, USA) and STATA v14.0.
